Document Detail


Gonadotrophins for idiopathic male factor subfertility.
MedLine Citation:
PMID:  16437514     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Male factor infertility accounts for 50% of infertility. The treatment of idiopathic male infertility is empirical. Urinary, purified, and recombinant gonadotrophins have been used to improve sperm parameters in idiopathic male infertility with the goal of increasing pregnancy rates. Research addressing pregnancy rates in partners of men treated with gonadotrophins has had conflicting results and needs to be analysed.
OBJECTIVES: To determine the effectiveness of gonadotrophin administration to men with idiopathic subfertility on spontaneous pregnancy rate and in assisted reproductive techniques (ARTs).
SEARCH STRATEGY: We searched the Cochrane Menstrual Disorders and Subfertility Group trials register (19 November 2004), the Cochrane Central Register of Controlled Trials (The Cochrane Library, issue 4, 2004), MEDLINE (1966 to April 2005), EMBASE and Biological Abstracts (1980 to November 2004). Searches were not limited by language. The bibliographies of included, excluded trials and abstracts of major meetings were searched for additional trials. Authors and pharmaceutical companies were contacted for missing and unpublished data.
SELECTION CRITERIA: Truly randomised controlled trials where gonadotrophins were administered for the treatment of idiopathic male subfertility with reporting of pregnancy rates were included in the review.
DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. Study authors were contacted for additional information. Adverse effects information was collected from the trials. We analysed data regarding pregnancy occurring within 3 months after gonadotrophin therapy.
MAIN RESULTS: Four RCTs with 278 participant were included in the analysis. None of the studies had an adequate sample size and they had variable follow-up periods. None of the studies reported live birth or miscarriage rates. Compared to placebo or no treatment, gonadotrophins showed a significantly higher pregnancy rate per couple randomized within 3 months of completing therapy (OR 3.03, 95% CI 1.30 to 7.09). Pregnancy rate was 13.4% (19/142) in the gonadotrophin group and 4.4% (6/136) in the control group.
AUTHORS' CONCLUSIONS: The number of trials and participants is insufficient to draw final conclusions. A large multicenter study with adequate power is needed.
Authors:
A M Attia; H G Al-Inany; M L Proctor
Related Documents :
16737024 - Ovulatory disorders and infertility.
2565314 - Empirical therapy of the male with clomiphene in couples with unexplained infertility.
2707464 - Pretreatment of sperm with human follicular fluid for borderline male infertility.
8401684 - Can staging systems for endometriosis based on anatomic location and lesion type predic...
2357664 - Ascariasis, respiratory diseases and production indices in selected prince edward islan...
8238154 - Uterine rupture after previous cesarean delivery: maternal and fetal consequences.
Publication Detail:
Type:  Journal Article; Review     Date:  2006-01-25
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2006  
Date Detail:
Created Date:  2006-01-26     Completed Date:  2006-04-07     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD005071     Citation Subset:  IM    
Affiliation:
Faculty Of Medicine, Cairo University, Obstetrics and Gynaecology, 18 El-Ghaith St., El-Agouza, Cairo, Egypt, 12311. amattia@link.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Follicle Stimulating Hormone / therapeutic use*
Gonadotropins / therapeutic use
Humans
Infertility, Male / drug therapy*
Male
Oligospermia / drug therapy
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Gonadotropins; 9002-68-0/Follicle Stimulating Hormone
Comments/Corrections
Update In:
Cochrane Database Syst Rev. 2007;(4):CD005071   [PMID:  17943837 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acid reflux treatment for hoarseness.
Next Document:  Uterine artery embolization for symptomatic uterine fibroids.